Compare Xelpmoc Design with Similar Stocks
Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -24.54% and Operating profit at -215.91% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -12.30
Flat results in Dec 25
Risky - Negative EBITDA
Stock DNA
Software Products
INR 153 Cr (Micro Cap)
NA (Loss Making)
24
0.00%
-0.12
-9.83%
1.96
Total Returns (Price + Dividend) 
Xelpmoc Design for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Xelpmoc Design and Tech Ltd is Rated Strong Sell
Xelpmoc Design and Tech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 20 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 May 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Xelpmoc Design and Tech Ltd is Rated Strong Sell
Xelpmoc Design and Tech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 20 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 May 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Xelpmoc Design and Tech Ltd is Rated Strong Sell
Xelpmoc Design and Tech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 20 Apr 2026, reflecting a significant reassessment of the stock’s outlook. However, the analysis below is based on the company’s current fundamentals, returns, and financial metrics as of 02 May 2026, providing investors with an up-to-date perspective on the stock’s position.
Read full news article Announcements 
Board Meeting Intimation for Audited Financial Results Of The Company For The Financial Year Ended March 31 2026
23-May-2026 | Source : BSEXelpmoc Design And Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the financial year ended March 31 2026.
Announcement Under Regulation 30 (LODR) - Intimation Regarding Dispute/Litigation
22-May-2026 | Source : BSEIntimation regarding dispute/litigation.
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
09-May-2026 | Source : BSEAllotment of Equity Shares pursuant to Employees Stock Options Scheme 2019
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 1 FIIs (0.06%)
Sandipan Chattopadhyay (27.64%)
Omprakash Kanayalal Shah (5.18%)
45.05%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 47.37% vs -2.56% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -3.63% vs -2.66% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -34.75% vs -46.61% in Sep 2024
Growth in half year ended Sep 2025 is 25.00% vs 37.21% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -16.61% vs -42.52% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 18.63% vs 4.16% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -39.72% vs -56.11% in Mar 2024
YoY Growth in year ended Mar 2025 is 39.11% vs 15.64% in Mar 2024






